Safety and efficacy of pulsed imatinib with or without G-CSF versus continuous imatinib in chronic phase chronic myeloid leukaemia patients at 5 years follow-up.
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Description
Keywords
BCR-ABL1, chronic myeloid leukaemia, stem cells, therapy, trials, Benzamides, Cell Cycle, Dasatinib, Drug Substitution, Drug Synergism, Follow-Up Studies, Fusion Proteins, bcr-abl, Granulocyte Colony-Stimulating Factor, Humans, Imatinib Mesylate, Leukemia, Myeloid, Chronic-Phase, Piperazines, Protein Kinase Inhibitors, Pulse Therapy, Drug, Pyrimidines, Thiazoles, Treatment Outcome
Journal Title
Br J Haematol
Conference Name
Journal ISSN
0007-1048
1365-2141
1365-2141
Volume Title
163
Publisher
Wiley
Publisher DOI
Rights and licensing
Except where otherwised noted, this item's license is described as http://www.rioxx.net/licenses/all-rights-reserved